ReviewBreast cancer research and treatment2021

Clinical trial data and emerging immunotherapeutic strategies: hormone receptor-positive, HER2- negative breast cancer.

Matthew R Kearney et al.PubMed ↗Publisher ↗

No numbers read from the abstract.